MK-0767

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0767, covering 2015-06-12 to 2015-06-12. Get the full timeline:

Most recent: Clinical Trial Update: MK0767 and Sulfonylurea Combination Study (0767-027) [Phase 3]